Procept biorobotics corporationPRCT.US Overview

US StockHealthcare

(No presentation for PRCT)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

PRCT Overall Performance

PRCT AI Analysis & Strategy

PRCT Recent Performance

-4.89%

Procept biorobotics corporation

0.81%

Avg of Sector

-1.14%

S&P500

PRCT PowerScanner

PRCT Key Information

PRCT Valuation Metrics

PRCT Earnings Table

PRCT Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.